Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0043320210440040378
Archives of Pharmacal Research
2021 Volume.44 No. 4 p.378 ~ p.401
Phytochemicals against anti?diabetic complications: targeting the advanced glycation end product signaling pathway
Parveen Amna

Sultana Razia
Lee Seung-Min
Kim Tae-Hun
Kim Sun-Yeou
Abstract
The role of advanced glycation end products (AGEs) is not limited to diabetes and diabetes-related complications. There are multiple modulators, including the receptor for advanced glycation end products, high mobility group box 1, glyoxalase 1, nuclear factor-kappa B, tumor necrosis factor-¥á, chronic unpredictable stress, reactive oxygen species, and inflammatory cytokines, which interact with AGE signaling and control diabetes, modulating these interacting modulators. The progression of diabetes, as well as related complications, can be controlled and treated. Natural products rich in bioactive constituents can interact with AGEs and their related mediators through various signaling cascades, thereby controlling and preventing the progression of diabetes. This review provides a deeper assessment of the signaling pathway, interactions between phytochemicals and AGEs, and its mediators, to develop a multifold therapeutic approach to prevent and treat diabetes and its related complications.
KEYWORD
Advanced glycation end products, Reactive oxygen species, Coronary artery disease, Diabetes, Receptor for advanced end product glycation, Nitric oxide, Phytochemicals
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)